Loading…

Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization

Purpose We evaluated the effects of the combination of Tirapazamine (TPZ), activated preferentially under hypoxic conditions, and gelatin microspheres (GMS) on the tumor growth ratio in rabbits. Methods We assigned 20 liver tumor-bearing Japanese white rabbits to 4 equal groups. Group 1 received 1 m...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2011-12, Vol.34 (6), p.1272-1277
Main Authors: Sonoda, Akinaga, Nitta, Norihisa, Ohta, Shinich, Nitta-Seko, Ayumi, Nagatani, Yukihiro, Takahashi, Masashi, Murata, Kiyoshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913
cites cdi_FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913
container_end_page 1277
container_issue 6
container_start_page 1272
container_title Cardiovascular and interventional radiology
container_volume 34
creator Sonoda, Akinaga
Nitta, Norihisa
Ohta, Shinich
Nitta-Seko, Ayumi
Nagatani, Yukihiro
Takahashi, Masashi
Murata, Kiyoshi
description Purpose We evaluated the effects of the combination of Tirapazamine (TPZ), activated preferentially under hypoxic conditions, and gelatin microspheres (GMS) on the tumor growth ratio in rabbits. Methods We assigned 20 liver tumor-bearing Japanese white rabbits to 4 equal groups. Group 1 received 1 ml of saline intra-arterially (i.a.) and 20 ml of saline intraperitoneally (i.p.; saline group). Group 2 was injected with GMS i.a. and 20 ml saline i.p. (GMS group). Group 3 received 1 ml of saline i.a. and 300 mg/m 2 of TPZ i.p. (TPZ group), and group 4 was treated with GMS i.a. and 300 mg/m 2 of TPZ i.p. (GMS + TPZ group). The infusion of GMS was stopped when the blood flow stagnated. Before and 7 days after treatment, the liver tumor volumes were measured as the total number of pixels on 0.3Tesla (T) magnetic resonance imaging (MRI) scans. Results The tumor growth ratio (mean ± standard deviation) of the saline, GMS, TPZ, and GMS + TPZ groups was 519.15 ± 93.78, 279.24 ± 91.83, 369.78 ± 95.73, and 119.87 ± 17.62, respectively. The difference between the GMS + TPZ group and the other groups was statistically significant ( P  
doi_str_mv 10.1007/s00270-011-0156-4
format article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21608659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>908011493</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0EopfCA7BBFixYpdhOnJ9lKRda6UqV4IK6syaOQ32V2KntILVPwuMyUUqRKrGwbI2-c8Yzh5DXnJ1wxqoPkTFRsYxxjkeWWfGEbHiRi4zV5dVTsmG8KjIuJT8iL2I8MIRqIZ-TI8GLqqkKuSG_t-4anDYdPXXJpnn0gW773uhEfU_3NsAEdzBaZ-gnM9hfJiB64RLWTbDJOwPDcEuTpz-uBN0tAN0vLtlHA8G6n_QrtK1NkX6b2wPaohzhfQAXIST0gIGemwmS1XQ7tn6wd_j27iV51sMQzav7-5h8_7zdn51nu8svF2enu0znTZ0yaTTvhWTAcyG11lKCrHVZlhxwClnKLgcNuhUd1FiqdJEz00PbARRl0_D8mLxbfX1MVkVtk9HX2juHf1WCl7hK2SD1fqWm4G9mE5MabdRmGMAZP0fVsBpTKJocybePyIOfg8MREKo4dpQlQnyFdPAxBtOrKdgRwq3iTC3RqjVahaZqiVYVqHlzbzy3o-keFH-zRECsQJyWxZvwr_P_Xf8Aek6xIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>907191356</pqid></control><display><type>article</type><title>Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization</title><source>Springer Nature</source><creator>Sonoda, Akinaga ; Nitta, Norihisa ; Ohta, Shinich ; Nitta-Seko, Ayumi ; Nagatani, Yukihiro ; Takahashi, Masashi ; Murata, Kiyoshi</creator><creatorcontrib>Sonoda, Akinaga ; Nitta, Norihisa ; Ohta, Shinich ; Nitta-Seko, Ayumi ; Nagatani, Yukihiro ; Takahashi, Masashi ; Murata, Kiyoshi</creatorcontrib><description>Purpose We evaluated the effects of the combination of Tirapazamine (TPZ), activated preferentially under hypoxic conditions, and gelatin microspheres (GMS) on the tumor growth ratio in rabbits. Methods We assigned 20 liver tumor-bearing Japanese white rabbits to 4 equal groups. Group 1 received 1 ml of saline intra-arterially (i.a.) and 20 ml of saline intraperitoneally (i.p.; saline group). Group 2 was injected with GMS i.a. and 20 ml saline i.p. (GMS group). Group 3 received 1 ml of saline i.a. and 300 mg/m 2 of TPZ i.p. (TPZ group), and group 4 was treated with GMS i.a. and 300 mg/m 2 of TPZ i.p. (GMS + TPZ group). The infusion of GMS was stopped when the blood flow stagnated. Before and 7 days after treatment, the liver tumor volumes were measured as the total number of pixels on 0.3Tesla (T) magnetic resonance imaging (MRI) scans. Results The tumor growth ratio (mean ± standard deviation) of the saline, GMS, TPZ, and GMS + TPZ groups was 519.15 ± 93.78, 279.24 ± 91.83, 369.78 ± 95.73, and 119.87 ± 17.62, respectively. The difference between the GMS + TPZ group and the other groups was statistically significant ( P  &lt; 0.05). Conclusions Our results show that the combination of TPZ i.p. and GMS i.a. enhanced the antitumor effect of TPZ. This procedure may represent a new alternative treatment for patients with hepatic cell carcinoma.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-011-0156-4</identifier><identifier>PMID: 21479745</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>ANIMALS ; Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Agents - pharmacology ; BLOOD FLOW ; BODY ; Carcinoma, Hepatocellular - therapy ; CARCINOMAS ; Cardiology ; COLLOIDS ; DIAGNOSTIC TECHNIQUES ; DIGESTIVE SYSTEM ; DISEASES ; DISPERSIONS ; GELATIN ; GLANDS ; Imaging ; Laboratory Investigation ; LIVER ; Liver Neoplasms, Experimental - therapy ; Magnetic Resonance Imaging ; MAMMALS ; Medicine ; Medicine &amp; Public Health ; MICROSPHERES ; NEOPLASMS ; NMR IMAGING ; Nuclear Medicine ; ORGANIC COMPOUNDS ; ORGANS ; PATIENTS ; PROTEINS ; RABBITS ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; Triazines - administration &amp; dosage ; Triazines - pharmacology ; Ultrasound ; VERTEBRATES</subject><ispartof>Cardiovascular and interventional radiology, 2011-12, Vol.34 (6), p.1272-1277</ispartof><rights>Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913</citedby><cites>FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21479745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21608659$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Sonoda, Akinaga</creatorcontrib><creatorcontrib>Nitta, Norihisa</creatorcontrib><creatorcontrib>Ohta, Shinich</creatorcontrib><creatorcontrib>Nitta-Seko, Ayumi</creatorcontrib><creatorcontrib>Nagatani, Yukihiro</creatorcontrib><creatorcontrib>Takahashi, Masashi</creatorcontrib><creatorcontrib>Murata, Kiyoshi</creatorcontrib><title>Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose We evaluated the effects of the combination of Tirapazamine (TPZ), activated preferentially under hypoxic conditions, and gelatin microspheres (GMS) on the tumor growth ratio in rabbits. Methods We assigned 20 liver tumor-bearing Japanese white rabbits to 4 equal groups. Group 1 received 1 ml of saline intra-arterially (i.a.) and 20 ml of saline intraperitoneally (i.p.; saline group). Group 2 was injected with GMS i.a. and 20 ml saline i.p. (GMS group). Group 3 received 1 ml of saline i.a. and 300 mg/m 2 of TPZ i.p. (TPZ group), and group 4 was treated with GMS i.a. and 300 mg/m 2 of TPZ i.p. (GMS + TPZ group). The infusion of GMS was stopped when the blood flow stagnated. Before and 7 days after treatment, the liver tumor volumes were measured as the total number of pixels on 0.3Tesla (T) magnetic resonance imaging (MRI) scans. Results The tumor growth ratio (mean ± standard deviation) of the saline, GMS, TPZ, and GMS + TPZ groups was 519.15 ± 93.78, 279.24 ± 91.83, 369.78 ± 95.73, and 119.87 ± 17.62, respectively. The difference between the GMS + TPZ group and the other groups was statistically significant ( P  &lt; 0.05). Conclusions Our results show that the combination of TPZ i.p. and GMS i.a. enhanced the antitumor effect of TPZ. This procedure may represent a new alternative treatment for patients with hepatic cell carcinoma.</description><subject>ANIMALS</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>BLOOD FLOW</subject><subject>BODY</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>CARCINOMAS</subject><subject>Cardiology</subject><subject>COLLOIDS</subject><subject>DIAGNOSTIC TECHNIQUES</subject><subject>DIGESTIVE SYSTEM</subject><subject>DISEASES</subject><subject>DISPERSIONS</subject><subject>GELATIN</subject><subject>GLANDS</subject><subject>Imaging</subject><subject>Laboratory Investigation</subject><subject>LIVER</subject><subject>Liver Neoplasms, Experimental - therapy</subject><subject>Magnetic Resonance Imaging</subject><subject>MAMMALS</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>MICROSPHERES</subject><subject>NEOPLASMS</subject><subject>NMR IMAGING</subject><subject>Nuclear Medicine</subject><subject>ORGANIC COMPOUNDS</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>PROTEINS</subject><subject>RABBITS</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Triazines - administration &amp; dosage</subject><subject>Triazines - pharmacology</subject><subject>Ultrasound</subject><subject>VERTEBRATES</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0EopfCA7BBFixYpdhOnJ9lKRda6UqV4IK6syaOQ32V2KntILVPwuMyUUqRKrGwbI2-c8Yzh5DXnJ1wxqoPkTFRsYxxjkeWWfGEbHiRi4zV5dVTsmG8KjIuJT8iL2I8MIRqIZ-TI8GLqqkKuSG_t-4anDYdPXXJpnn0gW773uhEfU_3NsAEdzBaZ-gnM9hfJiB64RLWTbDJOwPDcEuTpz-uBN0tAN0vLtlHA8G6n_QrtK1NkX6b2wPaohzhfQAXIST0gIGemwmS1XQ7tn6wd_j27iV51sMQzav7-5h8_7zdn51nu8svF2enu0znTZ0yaTTvhWTAcyG11lKCrHVZlhxwClnKLgcNuhUd1FiqdJEz00PbARRl0_D8mLxbfX1MVkVtk9HX2juHf1WCl7hK2SD1fqWm4G9mE5MabdRmGMAZP0fVsBpTKJocybePyIOfg8MREKo4dpQlQnyFdPAxBtOrKdgRwq3iTC3RqjVahaZqiVYVqHlzbzy3o-keFH-zRECsQJyWxZvwr_P_Xf8Aek6xIg</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Sonoda, Akinaga</creator><creator>Nitta, Norihisa</creator><creator>Ohta, Shinich</creator><creator>Nitta-Seko, Ayumi</creator><creator>Nagatani, Yukihiro</creator><creator>Takahashi, Masashi</creator><creator>Murata, Kiyoshi</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20111201</creationdate><title>Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization</title><author>Sonoda, Akinaga ; Nitta, Norihisa ; Ohta, Shinich ; Nitta-Seko, Ayumi ; Nagatani, Yukihiro ; Takahashi, Masashi ; Murata, Kiyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>ANIMALS</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>BLOOD FLOW</topic><topic>BODY</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>CARCINOMAS</topic><topic>Cardiology</topic><topic>COLLOIDS</topic><topic>DIAGNOSTIC TECHNIQUES</topic><topic>DIGESTIVE SYSTEM</topic><topic>DISEASES</topic><topic>DISPERSIONS</topic><topic>GELATIN</topic><topic>GLANDS</topic><topic>Imaging</topic><topic>Laboratory Investigation</topic><topic>LIVER</topic><topic>Liver Neoplasms, Experimental - therapy</topic><topic>Magnetic Resonance Imaging</topic><topic>MAMMALS</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>MICROSPHERES</topic><topic>NEOPLASMS</topic><topic>NMR IMAGING</topic><topic>Nuclear Medicine</topic><topic>ORGANIC COMPOUNDS</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>PROTEINS</topic><topic>RABBITS</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Triazines - administration &amp; dosage</topic><topic>Triazines - pharmacology</topic><topic>Ultrasound</topic><topic>VERTEBRATES</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sonoda, Akinaga</creatorcontrib><creatorcontrib>Nitta, Norihisa</creatorcontrib><creatorcontrib>Ohta, Shinich</creatorcontrib><creatorcontrib>Nitta-Seko, Ayumi</creatorcontrib><creatorcontrib>Nagatani, Yukihiro</creatorcontrib><creatorcontrib>Takahashi, Masashi</creatorcontrib><creatorcontrib>Murata, Kiyoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sonoda, Akinaga</au><au>Nitta, Norihisa</au><au>Ohta, Shinich</au><au>Nitta-Seko, Ayumi</au><au>Nagatani, Yukihiro</au><au>Takahashi, Masashi</au><au>Murata, Kiyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>34</volume><issue>6</issue><spage>1272</spage><epage>1277</epage><pages>1272-1277</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Purpose We evaluated the effects of the combination of Tirapazamine (TPZ), activated preferentially under hypoxic conditions, and gelatin microspheres (GMS) on the tumor growth ratio in rabbits. Methods We assigned 20 liver tumor-bearing Japanese white rabbits to 4 equal groups. Group 1 received 1 ml of saline intra-arterially (i.a.) and 20 ml of saline intraperitoneally (i.p.; saline group). Group 2 was injected with GMS i.a. and 20 ml saline i.p. (GMS group). Group 3 received 1 ml of saline i.a. and 300 mg/m 2 of TPZ i.p. (TPZ group), and group 4 was treated with GMS i.a. and 300 mg/m 2 of TPZ i.p. (GMS + TPZ group). The infusion of GMS was stopped when the blood flow stagnated. Before and 7 days after treatment, the liver tumor volumes were measured as the total number of pixels on 0.3Tesla (T) magnetic resonance imaging (MRI) scans. Results The tumor growth ratio (mean ± standard deviation) of the saline, GMS, TPZ, and GMS + TPZ groups was 519.15 ± 93.78, 279.24 ± 91.83, 369.78 ± 95.73, and 119.87 ± 17.62, respectively. The difference between the GMS + TPZ group and the other groups was statistically significant ( P  &lt; 0.05). Conclusions Our results show that the combination of TPZ i.p. and GMS i.a. enhanced the antitumor effect of TPZ. This procedure may represent a new alternative treatment for patients with hepatic cell carcinoma.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>21479745</pmid><doi>10.1007/s00270-011-0156-4</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0174-1551
ispartof Cardiovascular and interventional radiology, 2011-12, Vol.34 (6), p.1272-1277
issn 0174-1551
1432-086X
language eng
recordid cdi_osti_scitechconnect_21608659
source Springer Nature
subjects ANIMALS
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacology
BLOOD FLOW
BODY
Carcinoma, Hepatocellular - therapy
CARCINOMAS
Cardiology
COLLOIDS
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DISEASES
DISPERSIONS
GELATIN
GLANDS
Imaging
Laboratory Investigation
LIVER
Liver Neoplasms, Experimental - therapy
Magnetic Resonance Imaging
MAMMALS
Medicine
Medicine & Public Health
MICROSPHERES
NEOPLASMS
NMR IMAGING
Nuclear Medicine
ORGANIC COMPOUNDS
ORGANS
PATIENTS
PROTEINS
RABBITS
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Triazines - administration & dosage
Triazines - pharmacology
Ultrasound
VERTEBRATES
title Enhanced Antitumor Effect of Tirapazamine Delivered Intraperitoneally to VX2 Liver Tumor-Bearing Rabbits Subjected to Transarterial Hepatic Embolization
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A37%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20Antitumor%20Effect%20of%20Tirapazamine%20Delivered%20Intraperitoneally%20to%20VX2%20Liver%20Tumor-Bearing%20Rabbits%20Subjected%20to%20Transarterial%20Hepatic%20Embolization&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Sonoda,%20Akinaga&rft.date=2011-12-01&rft.volume=34&rft.issue=6&rft.spage=1272&rft.epage=1277&rft.pages=1272-1277&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-011-0156-4&rft_dat=%3Cproquest_osti_%3E908011493%3C/proquest_osti_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-5ec1f250a1325ccc55a58c6661affe565d3acacb2da81af7c430efabdaa469913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=907191356&rft_id=info:pmid/21479745&rfr_iscdi=true